Locations:
Abu Dhabi|Canada|Florida|London|Nevada|Ohio|
Gray gradientGray gradient
Cleveland Clinic icon
Consult QD logo
Search IconSearch

Tag: mitraclip

illustration of mitral valve transcatheter edge-to-edge repair

The Two FDA-Approved M-TEER Systems Are Comparable at 1-Year Follow-Up, CLASP IID Data Show

And substudy reveals good outcomes with PASCAL system in patients with complex mitral valve anatomy

23-HVI-3606658_mitraclip_650x450

Final COAPT Results Show TEER Benefits Through 5 Years in Secondary MR

Superiority continues even after significant crossovers from control group at 2 years

22-HVI-2768410_mitraclip_650x450

PRIMARY Trial Aims to Guide Choice of Percutaneous Vs. Surgical Repair of Degenerative Mitral Regurgitation

Essentials of the NIH study and how it compares with REPAIR MR

19-CCC-6017-top10Innov-2019-2_650x450

No. 2 Medical Innovation for 2020: Expanded Use of Minimally Invasive Mitral Valve Surgery

FDA makes MitraClip available to more patients with mitral regurgitation

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

18-HRT-5659-mitraclip-650×450

MitraClip Drives Down Deaths, HF Hospitalization in Secondary Mitral Regurgitation

COAPT trial gives boost to transcatheter mitral valve repair in selected heart failure patients

Robotic and catheter-based techniques

Managing Mitral Valve Disease in 2016

Robust robotics, preeminence of repair, and a rosy percutaneous future

TranscatheterValve-690×380

Transcatheter Valve Procedures Gain Steam with More Populations, New Applications

Percutaneous aortic and mitral approaches proliferate

MitraClip-690

MitraClip Reaches Real-World Use in U.S., but Population Refinement Remains

Filling unmet needs for nonsurgical mitral regurgitation therapy

BackPage 1 of 1Next

Advertisement

Ad